Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel

Children represent a significant proportion of the global tuberculosis (TB) burden, and may be disproportionately more affected by its most severe clinical manifestations. Currently available treatments for pediatric drug-susceptible (DS) and drug-resistant (DR) TB, albeit generally effective, are h...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachman, Sharon, Ahmed, Amina, Amanullah, Farhana, Becerra, Mercedes C, Botgros, Radu, Brigden, Grania, Browning, Renee, Gardiner, Elizabeth, Hafner, Richard, Hesseling, Anneke, How, Cleotilde, Jean-Philippe, Patrick, Lessem, Erica, Makhene, Mamodikoe, Mbelle, Nontombi, Marais, Ben, McIlleron, Helen, Mc Neeley, David F, Mendel, Carl, Murray, Stephen, Navarro, Eileen, Oramasionwu, Gloria E, Porcalla, Ariel R, Powell, Clydette, Powell, Mair, Rigaud, Mona, Rouzier, Vanessa, Samson, Pearl, Schaaf, H. Simon, Shah, Seema, Starke, Jeff, Swaminathan, Soumya, Wobudeya, Eric, Worrell, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471052/
https://www.ncbi.nlm.nih.gov/pubmed/25957923
http://dx.doi.org/10.1016/S1473-3099(15)00007-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471052/
https://www.ncbi.nlm.nih.gov/pubmed/25957923
http://dx.doi.org/10.1016/S1473-3099(15)00007-9

Ejemplares similares